US20120269673A1 - Magnesium alloy - Google Patents

Magnesium alloy Download PDF

Info

Publication number
US20120269673A1
US20120269673A1 US13/511,891 US201013511891A US2012269673A1 US 20120269673 A1 US20120269673 A1 US 20120269673A1 US 201013511891 A US201013511891 A US 201013511891A US 2012269673 A1 US2012269673 A1 US 2012269673A1
Authority
US
United States
Prior art keywords
magnesium
magnesium alloy
alloy
alloying element
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/511,891
Other languages
English (en)
Inventor
Ja-Kyo Koo
Hyun-Kwang Seok
Seok-Jo Yang
Yu-Chan Kim
Sung-youn Cho
Jong-Tack Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
U&I Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Assigned to U&I CORPORATION reassignment U&I CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SEOK, HYUN-KWANG, CHO, SUNG-YOUN, KIM, JONG-TACK, KIM, YU-CHAN, KOO, JA-KYO, YANG, SEOK-JO
Publication of US20120269673A1 publication Critical patent/US20120269673A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/04—Metals or alloys
    • A61L27/047—Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C1/00—Making non-ferrous alloys
    • C22C1/02—Making non-ferrous alloys by melting
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C23/00—Alloys based on magnesium
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C23/00—Alloys based on magnesium
    • C22C23/04—Alloys based on magnesium with zinc or cadmium as the next major constituent
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C23/00—Alloys based on magnesium
    • C22C23/06—Alloys based on magnesium with a rare earth metal as the next major constituent

Definitions

  • the present invention relates to a magnesium alloy.
  • Magnesium alloys are easily shaped, but have disadvantages of poor corrosion resistance and poor strength. Studies are continually performed with the aim of suitably changing the composition of magnesium alloys in order to improve the corrosion resistance and strength of magnesium alloys. In addition, studies have demonstrated that an increase in the amount of alloying elements in the magnesium alloy leads to an increase in the mechanical strength of the magnesium alloy. However, as the amount of alloying elements increases, several phases are formed, and an increase in the difference in electrical potential between these phases results in conditions such that a galvanic circuit, which increases the rate of corrosion of the alloy, is likely to be formed.
  • Another object of the present invention is to provide a magnesium alloy, the corrosion resistance and strength properties of which can be controlled through post-treatment processing.
  • the present invention provides a magnesium alloy having controlled corrosion resistance properties, which comprises magnesium (Mg) and an alloying element and includes a magnesium phase and a phase composed of magnesium and the alloying element, wherein the difference in electrical potential between the magnesium phase and the phase composed of magnesium and the alloying element is greater than 0 V but not greater than 0.2 V.
  • the present invention also provides a method for preparing a magnesium alloy having controlled corrosion resistance properties, the method comprising adding, to a magnesium alloy comprised of magnesium and an alloying element, a third element, thereby reducing the difference in electrical potential between a magnesium phase and a phase composed of magnesium and the alloying element to greater than 0 V but not greater than 0.2 V.
  • the corrosion resistance properties of the magnesium alloy according to the present invention can be controlled using the difference in electrical potential between the magnesium and the alloying element.
  • the corrosion resistance and strength properties of the magnesium alloy of the present invention can also be controlled through post-treatment processing.
  • the magnesium alloy can be used in the industrial and medical fields.
  • FIG. 1 is a graphic diagram showing the corrosion rates of the magnesium alloys of Examples 1 to 4 and Comparative Examples 1 and 2.
  • FIG. 2 is a graphic diagram showing the results of measurement of the strengths of the magnesium alloys of Example 1, Example 2 and Comparative Example 1.
  • FIG. 3 is a graphic diagram showing the results of measurement of the strengths of the magnesium alloys of Example 3, Example 4 and Comparative Example 2.
  • FIG. 4 is a photograph showing the alloy of Example 2 before and after surface treatment.
  • FIG. 5 is a graphic diagram showing the open circuit potentials of the magnesium alloys of Examples 5 to 9 and Comparative Example 1 as a function of time.
  • FIG. 6 is a graphic diagram showing the rate of generation of hydrogen as a function of the content of zinc.
  • FIG. 7 is a graphic diagram showing open circuit potential (electrical potential) as a function of the content of zinc.
  • FIG. 8 is a graphic diagram showing the rate of degradation as a function of the difference in open circuit potential (electrical potential).
  • the present invention is directed to a magnesium alloy having controlled corrosion resistance properties, which comprises magnesium (Mg) and an alloying element and includes a magnesium phase and a phase composed of magnesium and the alloying element.
  • the difference in electrical potential between the magnesium phase and the phase composed of magnesium and the alloying element is greater than 0 V but not greater than 0.2 V, and is preferably close to 0. If the magnesium alloy satisfies the above-described range, it has a very low rate of degradation, and thus can be effectively used in the industrial and medical fields. In addition, the magnesium alloy has excellent corrosion resistance and strength.
  • the alloying element is not specifically limited, as long as the difference in electrical potential between the magnesium phase and the phase composed of magnesium and the alloying element falls within the above-described range.
  • the alloying element include calcium (Ca), iron (Fe), manganese (Mn), cobalt (Co), nickel (Ni), chromium (Cr), copper (Cu), cadmium (Cd), zirconium (Zr), silver (Ag), gold (Au), palladium (Pd), platinum (Pt), rhenium (Re), iron (Fe), zinc (Zn), molybdenum (Mo), niobium (Nb), tantalum (Ta), titanium (Ti), strontium (Sr), silicon (Si), phosphorus (P) and selenium (Se).
  • the magnesium alloy that realizes the difference in electrical potential between the magnesium phase and the phase composed of magnesium and the alloying element is preferably represented by the following formula 1:
  • the amounts of Ca and X in the magnesium alloy of the present invention can be determined within the above-described ranges by taking into consideration the required strength of the alloy and the rates of degradation of the additional metals.
  • nickel When nickel (Ni) is included in X, nickel reduces the toxicity of the magnesium alloy and makes it possible to control the rate of corrosion of the magnesium alloy.
  • the content of nickel is preferably 100 ppm or less, and more preferably 50 ppm or less.
  • iron (Fe) when iron (Fe) is included in X, iron significantly influences the increase in the rate of corrosion of the magnesium, and for this reason, the content of iron is preferably 1,000 ppm or less, and more preferably 500 ppm or less. If iron is contained in an amount exceeding the upper limit of the above range, iron will be present as an independent factor, without being fixed to magnesium, thus increasing the rate of corrosion of the magnesium alloy.
  • the magnesium alloy that realizes the difference in electrical potential between the magnesium phase and the phase composed of magnesium and the alloying element is preferably represented by the following formula 2.
  • the magnesium alloy represented by formula 2 comprises, based on the total weight thereof, greater than 0 wt % but not greater than 23 wt % of calcium (Ca), greater than 0 wt % but not greater than 10 wt % of Y, and the balance of magnesium (Mg).
  • composition of the magnesium alloy represented by formula 2 falls within the above-described ranges, it has not only improved mechanical properties, but also improved corrosion resistance, and does not undergo brittle fracture.
  • the magnesium alloy represented by formula 2 preferably comprises, based on the total weight thereof, greater than 0 wt % but not greater than 23 wt % of calcium (Ca), 0.1-5 wt % of Y, and the balance of magnesium (Mg). More preferably, the magnesium alloy represented by formula 2 comprises greater than 0 wt % but not greater than 23 wt % of calcium (Ca), 0.1-3 wt % of Y, and the balance of Mg. The reason for this is that when the same corrosion rate is realized, taking into consideration the possible side effects of impurities, the contents of the impurities should preferably be low.
  • the magnesium alloy that realizes the difference in electrical potential between the magnesium phase and the phase composed of magnesium and the alloying element is preferably represented by the following formula 3.
  • the magnesium alloy represented by formula 3 comprises, based on the total weight thereof, greater than 0 wt % but no greater than 40 wt % of Z and the balance of magnesium (Mg).
  • Z is one or more selected from among manganese (Mn), cobalt (Co), nickel (Ni), chromium (Cr), copper (Cu), cadmium (Cd), zirconium (Zr), silver (Ag), gold (Au), palladium (Pd), platinum (Pt), rhenium (Re), iron (Fe), zinc (Zn), molybdenum (Mo), niobium (Nb), tantalum (Ta), titanium (Ti), strontium (Sr), silicon (Si), phosphorus (P) and selenium (Se).
  • the magnesium alloy is preferably subjected to surface treatment.
  • the surface treatment is preferably shot peening.
  • the magnesium alloy which is included in an implant of the present invention may be subjected to surface coating.
  • a corrosion-resistant product can be produced on the surface of the magnesium alloy, whereby the rate of degradation of the magnesium alloy can be delayed.
  • the surface coating may be performed with a ceramic and/or polymer material.
  • the coating of the magnesium alloy surface with a ceramic material will be described.
  • the surface of the magnesium alloy can be coated with a corrosion-resistant product.
  • the corrosion-resistant product may be a ceramic material, in which the ceramic material may be magnesium oxide or calcium phosphate.
  • the surface of the biodegradable magnesium alloy is coated with the corrosion-resistant product, it may further be coated with a polymer. Examples of the polymer which may be used in the present invention are as described below.
  • the polymer that is used to coat the surface of the magnesium alloy is not specifically limited, as long as it is one that is conventionally used in the art.
  • Preferred examples of the polymer for use in the present invention include poly(L-lactide), poly(glycolide), poly(DL-lactide), poly(dioxanone), poly(DL-lactide-co-L-lactide), poly(DL-lactide-co-glycolide), poly(glycolide-co-trimethylene carbonate), poly(L-lactide-co-glycolide), poly(e-caprolactone), and combinations thereof.
  • the magnesium alloy according to the present invention can be used in various ways. For example, it may be coated on the surface of ceramic, metal and polymer materials. In addition, the magnesium alloy according to the present invention may be used in combination with a ceramic or polymeric material.
  • the present invention also provides a method for preparing a magnesium alloy having controlled corrosion resistance properties, the method comprising adding, to a magnesium alloy comprised of magnesium and an alloying element, a third element, thereby reducing the difference in electrical potential between the magnesium phase and the phase composed of magnesium and the alloying element to greater than 0 V, but not greater than 0.2 V.
  • the magnesium alloy is preferably an alloy comprising magnesium and calcium.
  • the third element is preferably zinc.
  • the inventive method for preparing the magnesium alloy having controlled corrosion resistance properties may comprise the steps of: a) providing the magnesium alloy; and b) shaping the magnesium alloy.
  • Step a) of the method is preferably performed by melting the magnesium.
  • step a) may be performed by melting the magnesium in a vacuum atmosphere or in an atmosphere of inert gas such as argon (Ar), which does not react with magnesium.
  • step a) may be performed by melting the magnesium using various methods, such as a resistance heating method, in which heat is generated by electrically heating a resistive material, an induction heating method, in which a current is allowed to flow through an induction coil, or a method that uses a laser or focused light.
  • the resistance heating method is the most economical method.
  • the melted alloy hereinafter referred to as the “melt” is preferably stirred during the melting of magnesium such that impurities can be mixed well.
  • Step b) of the inventive method for preparing the magnesium alloy may be performed by shaping the molten magnesium alloy using one or more selected from the group consisting of a quenching method, an extrusion method, and a metal processing method.
  • the quenching method can be used in order to improve the mechanical strength of the magnesium alloy. More specifically, if magnesium is melted in step a), a method of immersing a crucible containing the molten magnesium in water may be used. In addition, a quenching method of spraying inert gas such as argon onto the molten magnesium may also be used. This spray-quenching method can quench the molten magnesium at a very high quenching rate, thereby realizing a very fine structure. However, in the case in which magnesium is cast in a small size, it should be noted that a plurality of pores (black portions) can also be formed.
  • the extrusion method is used to make the structure of the magnesium uniform and enhance the mechanical performance of the magnesium.
  • the extrusion method can control the strength and corrosion resistance properties of the magnesium alloy of the present invention.
  • the extrusion method is preferably performed at 300 ⁇ 450° C.
  • the extrusion of magnesium may be carried out at a ratio of reduction in the cross-sectional area before and after extrusion (an extrusion ratio) of 10:1 to 30:1.
  • an extrusion ratio As the extrusion ratio increases, the fine structure of the extruded material becomes more uniform, and defects formed during casting are easily removed. In this case, it is preferred to increase the capacity of the extrusion system.
  • the metal processing method is not particularly limited so long as it is known in the art.
  • Examples of the metal processing method include a method in which the molten magnesium is poured and cast in a mold that is processed such that it has a shape close to the shape of a final product; a method in which the molten magnesium is prepared into an intermediate material such as a rod or a sheet and is then subjected to turning or milling; and a method in which the magnesium alloy is forged at a higher pressure, thus obtaining a final product.
  • the magnesium alloys of Examples 1 and 2 and Comparative Example 1 were extruded.
  • the extrusion was performed at 370-375° C., and the ratio of reduction in the cross-sectional area before and after extrusion (the extrusion ratio) was set at 15:1.
  • the extruded alloy of Example 2 corresponds to the magnesium alloy of Example 1
  • the extruded alloy of Example 4 corresponds to the magnesium alloy of Example 2
  • the extruded alloy of Comparative Example 2 corresponds to the magnesium alloy of Comparative Example 1.
  • the rate of corrosion of magnesium alloys is determined by measuring the amount of hydrogen generated when the magnesium alloy is immersed in the solution shown in Table 2 below. This is because the biodegradation of magnesium results in the generation of hydrogen and the solution shown in Table 2 is a biomimetic solution.
  • FIG. 1 is a graphic diagram showing the rates of corrosion of the magnesium alloys of Examples 1 to 4 and Comparative Examples 1 and 2.
  • the corrosion resistance properties of the magnesium alloys were significantly improved when the alloying element was added and extrusion was performed. This suggests that the rate of degradation of magnesium alloys can be controlled to various levels using an alloying element and a post-treatment process.
  • the magnesium alloys of Examples 1 to 4 and Comparative Examples 1 and 2 were electric-discharge-machined into specimens having a diameter of 3 mm and a length of 6 mm.
  • the upper and lower surfaces of the specimens were polished with #1000 emery paper to adjust the level of the surface.
  • the specimens were horizontally placed on a jig made of tungsten carbide, and then a force was vertically applied to the specimens using the head of a compression tester with a maximum load of 20 tons. At this time, the vertical speed of the head was 10 ⁇ 4 /s.
  • the changes in strain and compressive stress were recorded in real time using an extensometer and a load cell provided in the compression tester.
  • the size of the specimen was too small to place the extensometer in the specimen, so the extensometer was placed in the jig of the tester that was used to press the specimen. Therefore, the strain of the specimen was measured as higher than its actual strain.
  • FIG. 2 is a graphic diagram showing the results of measurement of the strengths of the magnesium alloys of Examples 1 and 2 and Comparative Example 1.
  • FIG. 3 is a graphic diagram showing the results of measurement of the strengths of the magnesium alloys of Examples 3 and 4 and Comparative Example 2.
  • Table 3 shows the strengths of the magnesium alloys of Examples 1 to 4 and Comparative Examples 1 and 2.
  • Y.S indicates yield strength
  • UCS indicates ultimate compression strength.
  • the magnesium alloys of Examples 1 to 4 according to the present invention can be controlled to have corrosion resistance properties ranging from 2-3 days to 2 years and strengths of 87 MPa to 400 MPa by controlling the composition of the alloy and performing the post-treatment processing (extrusion).
  • a magnesium alloy that can maintain its strength for a required period of time can be prepared based on the above findings.
  • the alloy of Example 2 was subjected to surface treatment (shot peening), and the results of the treatment are shown in FIG. 4 .
  • the upper portion of FIG. 4 shows the alloy before surface treatment, and the lower portion shows the alloy after surface treatment.
  • Magnesium alloys of Examples 5 to 9 were prepared using the compositions shown in Table 4 below according to the method of Example 1.
  • Example 6 Example 7
  • Example 8 Example 9 Mg 2 Ca 93.65 95.78 97.89 99.58 100 (wt %) Zn (wt %) 6.35 4.22 2.11 0.42 0
  • FIG. 5 is a graphic diagram showing the open circuit potentials of the magnesium alloys of Examples 5 to 9 and Comparative Example 1 as a function of time.
  • the magnesium alloys of Comparative Example 1 and Example 5 showed the smallest difference in open circuit potential, indicating the best corrosion resistance, but the magnesium alloys of Comparative Example 1 and Example 9 showed a great difference in open circuit potential, indicating the highest corrosion rate.
  • the corrosion rates of the magnesium alloys were determined by measuring the amount of hydrogen that was generated when the magnesium alloys were immersed in the solution of Table 2 above.
  • FIG. 6 is a graphic diagram showing the rate of generation of hydrogen as a function of the content of zinc.
  • the x-axis indicates the Zn (at %) content in magnesium alloy containing Mg 2 Ca.
  • FIG. 7 is a graphic diagram showing the open circuit potential (electrical potential) as a function of the content of zinc.
  • the x-axis indicates the Zn (at %) content in magnesium alloy containing Mg 2 Ca.
  • FIG. 8 shows the rate of degradation of a magnesium alloy as a function of the difference in open circuit potential.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Prevention Of Electric Corrosion (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Conductive Materials (AREA)
US13/511,891 2009-12-07 2010-12-07 Magnesium alloy Abandoned US20120269673A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20090120356 2009-12-07
KR10-2009-0120356 2009-12-07
PCT/KR2010/008725 WO2011071304A2 (ko) 2009-12-07 2010-12-07 마그네슘 합금

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/008725 A-371-Of-International WO2011071304A2 (ko) 2009-12-07 2010-12-07 마그네슘 합금

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/373,538 Division US9943625B2 (en) 2009-12-07 2016-12-09 Magnesium alloy

Publications (1)

Publication Number Publication Date
US20120269673A1 true US20120269673A1 (en) 2012-10-25

Family

ID=44146044

Family Applications (2)

Application Number Title Priority Date Filing Date
US13/511,891 Abandoned US20120269673A1 (en) 2009-12-07 2010-12-07 Magnesium alloy
US15/373,538 Active US9943625B2 (en) 2009-12-07 2016-12-09 Magnesium alloy

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/373,538 Active US9943625B2 (en) 2009-12-07 2016-12-09 Magnesium alloy

Country Status (7)

Country Link
US (2) US20120269673A1 (de)
EP (1) EP2511390A4 (de)
JP (1) JP5894079B2 (de)
KR (1) KR101470052B1 (de)
CN (1) CN102648300B (de)
AU (1) AU2010328809B2 (de)
WO (1) WO2011071304A2 (de)

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103789588A (zh) * 2014-01-27 2014-05-14 贵研铂业股份有限公司 一种镁基海水自溶材料及其制备方法
WO2014145672A1 (en) * 2013-03-15 2014-09-18 Thixomat, Inc. High strength and bio-absorbable magnesium alloys
US20140277328A1 (en) * 2013-03-14 2014-09-18 St. Jude Medical Systems Ab Composite material and uses thereof
JP2016519718A (ja) * 2013-04-10 2016-07-07 ブルーンケ・ウルリヒ アルミニウム不含のマグネシウム合金
US9707739B2 (en) 2011-07-22 2017-07-18 Baker Hughes Incorporated Intermetallic metallic composite, method of manufacture thereof and articles comprising the same
US9816339B2 (en) 2013-09-03 2017-11-14 Baker Hughes, A Ge Company, Llc Plug reception assembly and method of reducing restriction in a borehole
US9926766B2 (en) 2012-01-25 2018-03-27 Baker Hughes, A Ge Company, Llc Seat for a tubular treating system
US10016810B2 (en) 2015-12-14 2018-07-10 Baker Hughes, A Ge Company, Llc Methods of manufacturing degradable tools using a galvanic carrier and tools manufactured thereof
US10196715B2 (en) 2013-03-14 2019-02-05 DePuy Synthes Products, Inc. Magnesium alloy with adjustable degradation rate
US10213522B2 (en) 2012-08-31 2019-02-26 DePuy Synthes Products, Inc. Ultrapure magnesium alloy with adjustable degradation rate
US10221637B2 (en) 2015-08-11 2019-03-05 Baker Hughes, A Ge Company, Llc Methods of manufacturing dissolvable tools via liquid-solid state molding
US10240419B2 (en) 2009-12-08 2019-03-26 Baker Hughes, A Ge Company, Llc Downhole flow inhibition tool and method of unplugging a seat
US10246763B2 (en) 2012-08-24 2019-04-02 The Regents Of The University Of California Magnesium-zinc-strontium alloys for medical implants and devices
US10301909B2 (en) 2011-08-17 2019-05-28 Baker Hughes, A Ge Company, Llc Selectively degradable passage restriction
US10344365B2 (en) 2012-06-26 2019-07-09 Biotronik Ag Magnesium-zinc-calcium alloy and method for producing implants containing the same
US10358709B2 (en) 2012-06-26 2019-07-23 Biotronik Ag Magnesium-zinc-calcium alloy, method for production thereof, and use thereof
US10378303B2 (en) 2015-03-05 2019-08-13 Baker Hughes, A Ge Company, Llc Downhole tool and method of forming the same
US10478529B2 (en) 2013-03-14 2019-11-19 DePuy Synthes Products, Inc. Magnesium alloy with adjustable degradation rate
US10895000B2 (en) 2012-06-26 2021-01-19 Biotronik Ag Magnesium alloy, method for the production thereof and use thereof
US10995398B2 (en) 2012-06-26 2021-05-04 Biotronik Ag Corrosion resistant stent
US11090719B2 (en) 2011-08-30 2021-08-17 Baker Hughes, A Ge Company, Llc Aluminum alloy powder metal compact
WO2021215543A1 (ja) * 2020-04-21 2021-10-28 国立大学法人 熊本大学 インプラント用マグネシウム合金、骨固定具、インプラント用マグネシウム合金の製造方法及び骨固定具の製造方法
US11167343B2 (en) 2014-02-21 2021-11-09 Terves, Llc Galvanically-active in situ formed particles for controlled rate dissolving tools
US11365164B2 (en) 2014-02-21 2022-06-21 Terves, Llc Fluid activated disintegrating metal system
US11649526B2 (en) 2017-07-27 2023-05-16 Terves, Llc Degradable metal matrix composite
US12018356B2 (en) 2020-06-08 2024-06-25 Terves Inc. Galvanically-active in situ formed particles for controlled rate dissolving tools

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103266251B (zh) * 2013-05-31 2015-09-02 滁州市昊宇滑动轴承有限公司 耐腐蚀塑料合金
CN104513922A (zh) * 2013-09-27 2015-04-15 上海交通大学医学院附属第九人民医院 具有抗菌功能的可体液降解的医用金属材料及其应用
SI2857536T1 (sl) 2013-10-03 2016-06-30 Annelie-Martina Weinberg Implantat za bolnike, ki rastejo, postopek za njegovo pripravo in uporaba
CN104593650A (zh) * 2013-11-01 2015-05-06 上海交通大学医学院附属第九人民医院 一种具有抗菌功能可降解吸收的镁锌铜合金及其应用
CN104645422B (zh) * 2013-11-21 2018-11-02 中国科学院金属研究所 一种具有强烈抗菌功能的生物可降解镁合金
CN103695747B (zh) * 2014-01-16 2015-11-04 陆明军 一种高强耐热镁合金及其制备方法
KR20160025898A (ko) 2014-08-28 2016-03-09 홍익대학교 산학협력단 기계적 물성과 생분해성이 우수한 마그네슘 합금 판재 및 그 제조방법
CN104178673B (zh) * 2014-09-12 2016-08-24 胡贤晨 一种镁合金及其制备方法
CN106244891A (zh) * 2014-11-10 2016-12-21 吴小再 使用寿命较长的耐腐蚀生物医用镁合金的制备方法
CN104451302A (zh) * 2014-11-14 2015-03-25 苏州蔻美新材料有限公司 一种医用镁合金材料及其制备方法
CN104762542B (zh) * 2015-03-26 2017-01-25 中国科学院金属研究所 生物医用可降解吸收Mg‑Sr‑Cu合金材料及制备方法和应用
CN106048347A (zh) * 2015-04-15 2016-10-26 丁永新 机械强度和生物相容性较好的医用镁基合金材料
CN105112822A (zh) * 2015-09-14 2015-12-02 苏州法斯特信息科技有限公司 一种抗腐蚀镁钒锶合金材料及其制备方法
CN106151793B (zh) * 2016-08-29 2018-07-31 陈亮 一种异形齿轮传动展示装置
CN109923229A (zh) * 2016-11-04 2019-06-21 通用汽车环球科技运作有限责任公司 耐腐蚀镁合金
CN108203782B (zh) * 2016-12-19 2020-08-28 有研工程技术研究院有限公司 一种具有电磁屏蔽功能的镁合金及其制备方法
CN109022978A (zh) * 2017-05-19 2018-12-18 曹丹丹 镁合金的制备方法
CN107435113B (zh) * 2017-07-10 2019-06-25 太原理工大学 一种在生物体内可降解的高强韧耐腐蚀骨科用镁合金及其制备方法
CN107435116B (zh) * 2017-07-10 2019-06-11 太原理工大学 一种镁合金生物植入材料及其制备方法
CN107354354A (zh) * 2017-09-15 2017-11-17 广州宇智科技有限公司 一种具有高阻尼含双相α+β的镁锂合金及其加工工艺
CN107815574A (zh) * 2017-09-28 2018-03-20 江苏晶王新材料科技有限公司 一种耐腐蚀的镁合金材料
CN108570587A (zh) * 2017-12-13 2018-09-25 湖南工程学院 一种耐热耐蚀镁合金及其制备方法
CN107974567A (zh) * 2018-01-30 2018-05-01 山东建筑大学 一种可控的医用降解镁合金的制备工艺与方法
CN108842105A (zh) * 2018-07-02 2018-11-20 许小忠 一种厨具用镁锌硒合金材料及其制备方法
CN109280828B (zh) * 2018-12-10 2021-03-02 南京工程学院 一种高强度可降解植入器械用复合材料及其制备方法
CN109778037B (zh) * 2019-03-14 2020-07-28 广西大学 一种抗菌镁合金骨科材料及其制备方法
CN110205531B (zh) * 2019-06-21 2020-12-15 北京万洁天元医疗器械股份有限公司 一种可降解镁合金及其制备方法
CN111411278B (zh) * 2020-05-07 2021-08-10 有研工程技术研究院有限公司 用于提高人体免疫力的离子缓释镁基合金及其制备方法
CN111411277A (zh) * 2020-05-21 2020-07-14 吉林大学 一种提高镁抗氧化能力的方法及镁钙合金
CN112316206B (zh) * 2020-11-06 2022-09-02 中南大学湘雅三医院 含有再吸收的金属材料的植入物及其制造方法
CN113122761A (zh) * 2021-03-09 2021-07-16 珠海中科先进技术研究院有限公司 一种可降解、强韧性的镁合金及其制备方法和应用
US20220354607A1 (en) 2021-05-10 2022-11-10 Cilag Gmbh International Packaging assemblies for surgical staple cartridges containing bioabsorbable staples

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304260A (en) * 1989-07-13 1994-04-19 Yoshida Kogyo K.K. High strength magnesium-based alloys

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2725112B2 (ja) * 1992-03-25 1998-03-09 三井金属鉱業株式会社 高強度マグネシウム合金
JP3204572B2 (ja) * 1993-06-30 2001-09-04 株式会社豊田中央研究所 耐熱マグネシウム合金
JPH10140304A (ja) * 1996-11-01 1998-05-26 Toyota Central Res & Dev Lab Inc マグネシウム合金の熱処理方法
JP2007270159A (ja) * 2004-06-03 2007-10-18 Ryobi Ltd 耐クリープマグネシウム合金
DE102007007879A1 (de) * 2007-02-14 2008-08-21 Gkss-Forschungszentrum Geesthacht Gmbh Beschichtung eines Bauteils

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304260A (en) * 1989-07-13 1994-04-19 Yoshida Kogyo K.K. High strength magnesium-based alloys

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10669797B2 (en) 2009-12-08 2020-06-02 Baker Hughes, A Ge Company, Llc Tool configured to dissolve in a selected subsurface environment
US10240419B2 (en) 2009-12-08 2019-03-26 Baker Hughes, A Ge Company, Llc Downhole flow inhibition tool and method of unplugging a seat
US9707739B2 (en) 2011-07-22 2017-07-18 Baker Hughes Incorporated Intermetallic metallic composite, method of manufacture thereof and articles comprising the same
US10697266B2 (en) 2011-07-22 2020-06-30 Baker Hughes, A Ge Company, Llc Intermetallic metallic composite, method of manufacture thereof and articles comprising the same
US10301909B2 (en) 2011-08-17 2019-05-28 Baker Hughes, A Ge Company, Llc Selectively degradable passage restriction
US11090719B2 (en) 2011-08-30 2021-08-17 Baker Hughes, A Ge Company, Llc Aluminum alloy powder metal compact
US9926766B2 (en) 2012-01-25 2018-03-27 Baker Hughes, A Ge Company, Llc Seat for a tubular treating system
US11499214B2 (en) 2012-06-26 2022-11-15 Biotronik Ag Magnesium-zinc-calcium alloy and method for producing implants containing the same
US10995398B2 (en) 2012-06-26 2021-05-04 Biotronik Ag Corrosion resistant stent
US10895000B2 (en) 2012-06-26 2021-01-19 Biotronik Ag Magnesium alloy, method for the production thereof and use thereof
US10358709B2 (en) 2012-06-26 2019-07-23 Biotronik Ag Magnesium-zinc-calcium alloy, method for production thereof, and use thereof
US10344365B2 (en) 2012-06-26 2019-07-09 Biotronik Ag Magnesium-zinc-calcium alloy and method for producing implants containing the same
US10246763B2 (en) 2012-08-24 2019-04-02 The Regents Of The University Of California Magnesium-zinc-strontium alloys for medical implants and devices
US10213522B2 (en) 2012-08-31 2019-02-26 DePuy Synthes Products, Inc. Ultrapure magnesium alloy with adjustable degradation rate
US10478529B2 (en) 2013-03-14 2019-11-19 DePuy Synthes Products, Inc. Magnesium alloy with adjustable degradation rate
US10196715B2 (en) 2013-03-14 2019-02-05 DePuy Synthes Products, Inc. Magnesium alloy with adjustable degradation rate
JP2014177699A (ja) * 2013-03-14 2014-09-25 St Jude Medical Systems Ab 複合材料及びその製造方法、医療用インプラント及びその製造方法、ならびに患者の体内における水素ガス放出を減少させる方法
US20140277328A1 (en) * 2013-03-14 2014-09-18 St. Jude Medical Systems Ab Composite material and uses thereof
CN105120907A (zh) * 2013-03-15 2015-12-02 西克索马特公司 高强度和生物可吸收的镁合金
US10022470B2 (en) 2013-03-15 2018-07-17 Thixomat, Inc. High-strength and bio-absorbable magnesium alloys
WO2014145672A1 (en) * 2013-03-15 2014-09-18 Thixomat, Inc. High strength and bio-absorbable magnesium alloys
JP2016519718A (ja) * 2013-04-10 2016-07-07 ブルーンケ・ウルリヒ アルミニウム不含のマグネシウム合金
US9816339B2 (en) 2013-09-03 2017-11-14 Baker Hughes, A Ge Company, Llc Plug reception assembly and method of reducing restriction in a borehole
CN103789588A (zh) * 2014-01-27 2014-05-14 贵研铂业股份有限公司 一种镁基海水自溶材料及其制备方法
US11167343B2 (en) 2014-02-21 2021-11-09 Terves, Llc Galvanically-active in situ formed particles for controlled rate dissolving tools
US11613952B2 (en) 2014-02-21 2023-03-28 Terves, Llc Fluid activated disintegrating metal system
US11365164B2 (en) 2014-02-21 2022-06-21 Terves, Llc Fluid activated disintegrating metal system
US10378303B2 (en) 2015-03-05 2019-08-13 Baker Hughes, A Ge Company, Llc Downhole tool and method of forming the same
US10221637B2 (en) 2015-08-11 2019-03-05 Baker Hughes, A Ge Company, Llc Methods of manufacturing dissolvable tools via liquid-solid state molding
US10016810B2 (en) 2015-12-14 2018-07-10 Baker Hughes, A Ge Company, Llc Methods of manufacturing degradable tools using a galvanic carrier and tools manufactured thereof
US11649526B2 (en) 2017-07-27 2023-05-16 Terves, Llc Degradable metal matrix composite
US11898223B2 (en) 2017-07-27 2024-02-13 Terves, Llc Degradable metal matrix composite
WO2021215543A1 (ja) * 2020-04-21 2021-10-28 国立大学法人 熊本大学 インプラント用マグネシウム合金、骨固定具、インプラント用マグネシウム合金の製造方法及び骨固定具の製造方法
US12018356B2 (en) 2020-06-08 2024-06-25 Terves Inc. Galvanically-active in situ formed particles for controlled rate dissolving tools

Also Published As

Publication number Publication date
EP2511390A2 (de) 2012-10-17
WO2011071304A3 (ko) 2011-10-27
KR20110084100A (ko) 2011-07-21
EP2511390A4 (de) 2017-05-31
JP5894079B2 (ja) 2016-03-23
AU2010328809A1 (en) 2012-07-05
AU2010328809B2 (en) 2014-09-11
JP2013512346A (ja) 2013-04-11
US20170119922A1 (en) 2017-05-04
US9943625B2 (en) 2018-04-17
KR101470052B1 (ko) 2014-12-11
CN102648300A (zh) 2012-08-22
WO2011071304A2 (ko) 2011-06-16
CN102648300B (zh) 2015-06-17

Similar Documents

Publication Publication Date Title
US9943625B2 (en) Magnesium alloy
EP2350330B1 (de) Seltenerdmetalle enthaltende magnesiumlegierungen
EP2496724B1 (de) Ni-Ti-HALBERZEUGNISSE UND ENTSPRECHENDE VERFAHREN
EP2758557B1 (de) Verbesserte aluminiumgusslegierungen mit vanadium
JP6607464B2 (ja) 成形可能なマグネシウム型の展伸用合金
EP2063816A1 (de) Implantate mit biologisch abbaubaren metallen und herstellungsverfahren dafür
KR20100116566A (ko) 생체분해성 임플란트 및 이의 제조방법
JP2009530496A (ja) 機械的特性および腐食特性の優れた組み合わせを有するマグネシウム系合金
EP3569723B1 (de) Magnesiumlegierung
CN104862524A (zh) 一种高强度合金及其制备方法
CN105525134A (zh) 一种高强度合金及其制备方法
EP3399060B1 (de) Verfahren zur herstellung von magnesiumlegierung mit ausgezeichneten mechanischen eigenschaften und korrosionsbeständigkeit
JP4081537B2 (ja) 生体用Ｃｏ基合金及びその製造方法
CN112063937B (zh) 一种无镍无铍的锆基非晶合金及其制备方法与应用
KR101485296B1 (ko) 생체분해성 임플란트 및 이의 제조방법
RU2798517C1 (ru) Низколегированный титановый сплав
JP3799478B2 (ja) チタン合金製トーションバー
Suliman et al. Mechanical Properties Evaluation of Magnesium-Based Alloy Used for Dental Implant Synthesis
CZ2014929A3 (cs) Slitina na bázi titanu a způsob jejího tepelně-mechanického zpracování
Byeon EFFECT OF INDIUM ADDITION ON MICROSTRUCTURE AND STRENGTH OF Au–Pt–Cu–Sn DENTAL BIOMATERIAL
Del Corso Effect of Cold Drawing & Heat Treating on Powder Metallurgy Processed ASTM F 1537 Alloy 1 & Alloy 2 Barstock
KR20110063962A (ko) 일회용품

Legal Events

Date Code Title Description
AS Assignment

Owner name: U&I CORPORATION, KOREA, REPUBLIC OF

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KOO, JA-KYO;SEOK, HYUN-KWANG;YANG, SEOK-JO;AND OTHERS;SIGNING DATES FROM 20120514 TO 20120518;REEL/FRAME:028266/0513

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION